5.70
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit - Yahoo Finance
Dystrophic Epidermolysis Bullosa Market to Reach New Heights - openPR
Abeona Therapeutics (NASDAQ:ABEO) Raised to Hold at StockNews.com - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Director Sells $21,520.00 in Stock - MarketBeat
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Abeona's Strategic Move: 13,000 Restricted Shares Granted to Key New Hires - StockTitan
Insider Sell: Mark Alvino Sells 4,000 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus.com
JPMorgan Chase & Co. Buys 28,606 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued (ABEO) - Seeking Alpha
Mark Alvino Sells 4,000 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) Stock - MarketBeat
Abeona Therapeutics director Mark Alvino sells $20,400 in stock - Investing.com
(ABEO) Investment Analysis and Advice - Stock Traders Daily
Abeona Therapeutics Inc (NASDAQ:ABEO) Stake Cut by Barclays PLC - Defense World
Jane Street Group LLC Invests $84,000 in Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Lowered by StockNews.com - Defense World
(ABEO) Trading Advice - Stock Traders Daily
Abeona Therapeutics (NASDAQ:ABEO) Cut to Sell at StockNews.com - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Acquired by Geode Capital Management LLC - Defense World
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Sold by Barclays PLC - Defense World
State Street Corp Sells 2,600 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI - GlobeNewswire Inc.
Abeona Therapeutics Awards Equity Incentives to New Employees in Strategic Talent Acquisition Move - StockTitan
Abeona Therapeutics (NASDAQ:ABEO) Upgraded to "Hold" at StockNews.com - MarketBeat
StockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to “Hold” - Defense World
Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO), - Yahoo Finance
Abeona Therapeutics Inc. Receives Stockholder Approval for Equity Incentive Plan Amendment - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Raised to “Hold” at StockNews.com - Defense World
StockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to Hold - MarketBeat
(ABEO) On The My Stocks Page - Stock Traders Daily
Charles Schwab Investment Management Inc. Purchases Shares of 23,850 Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Rating Lowered to Sell at StockNews.com - MarketBeat
When the Price of (ABEO) Talks, People Listen - Stock Traders Daily
Abeona Therapeutics Inc (NASDAQ:ABEO) is Western Standard LLC's 3rd Largest Position - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Holdings Lowered by Ikarian Capital LLC - MarketBeat
Abeona Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - XM
Abeona Therapeutics announces new employee inducement grants - TipRanks
Abeona Therapeutics Grants 44,700 Restricted Shares to New Employees as Incentive - StockTitan
Walleye Capital LLC Sells 129,083 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) - MarketBeat
Abeona Therapeutics Inc.'s (NASDAQ:ABEO) large institutional owners must be happy as stock continues to impress, up 11% over the past week - Simply Wall St
What is HC Wainwright's Estimate for ABEO FY2024 Earnings? - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Sold by Propel Bio Management LLC - MarketBeat
Abeona shares retain Buy rating; H.C. Wainwright sees approval potential for pz-cel in RDEB - Investing.com UK
Abeona Therapeutics (NASDAQ:ABEO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Earnings call: Abeona Therapeutics Q3 2024 results and PZ cell update - Investing.com Canada
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):